New Multi-site Phase 2 Ebola Vaccine Study Begins in Africa
New Multi-site Phase 2 Ebola Vaccine Study Begins in Africa
The U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research (WRAIR) initiated a Phase 2 clinical trial to evaluate the safety and immunogenicity of a prime-boost Ebola vaccine regimen in both healthy and HIV-infected volunteers. The multisite study began today with its first vaccination in…